| Apr 16, 2024 | Rivos | $250.0M Series A Extension | David Goel | Cambium Capital, Dell Technologies Capital, Hotung Venture Group, Intel, Koch Disruptive Technologies, MediaTek, Lip-Bu Tan |
| Jun 1, 2023 | AltPep | $53.0M Series B | Rohit Vanjani | Noga Yerushalmi, Sanofi Ventures, Section 32, Vertex Ventures Israel, Sigalit Klimovsky, Alexandria Venture Investments, Ronald DeMattos, Partners Investment |
| May 1, 2023 | ElevateBio | $400.0M Series D | AyurMaya, Matrix Capital Management | MPM Capital, RA Capital, EcoR1 Capital, EDBI, Emerson Collective, F2 Ventures, Fidelity Management & Research Company, Khalil Barrage, Lee Family Office, Karina Thorn, R&D partner, Redmile Group, Samsara BioCapital, SoftBank, Surveyor Capital, Vertex Ventures, Woodline Partners |
| May 1, 2022 | Talos | $110.0M Series B | General Atlantic | Baukunst, Jenny Fielding, Scott Hartley, FJ Labs, Giza Polish Ventures, Initialized Capital, Partech Ventures, Trammell Venture Partners, Y Combinator, Balaji Srinivasan, Hakan Koc, William Wolf, Andreessen Horowitz, Jason Vitale, Citi, DRW Venture Capital, Fidelity Management & Research Company, Graticule Asset Management Asia, Illuminate Financial, LeadBlock Partners, Notation Capital, PayPal Ventures, SCB 10X, Ken Fox, Voyager, Wells Fargo Strategic Capital |
| Feb 1, 2022 | Koneksa Health | $45.0M Series C | Matrix Capital Management | 4BIO Capital, Takeda Ventures, McKesson Ventures, Merck, Novartis, Quark Venture, Velosity Capital, Waterline Ventures |
| Jan 6, 2022 | ACELYRIN, INC. | $200.0M Other Equity | Alan Colowick | — |
| Jan 1, 2022 | Blockdaemon | $210.0M Series C | Sapphire Ventures, John Curtius | 305 Ventures, Andreessen Horowitz, Bain Capital Ventures, B Capital Group, Boldstart Ventures, Bora&Sons, Dreamers VC, Founders Fund, Gaingels, GitHub Fund, Goat Capital, Great Oaks Venture Capital, Hitachi Ventures, Laurence Jones, Softbank Group, Streamlined Ventures, SV Angel, Tenaya Capital, Thomvest Ventures, Trajectory Ventures, Uncork Capital, UpHonest Capital, U.S. Department Of Defense, Walden Catalyst Ventures, Workday Ventures, Y Combinator, Adam Gross, Edith Harbaugh, Guy Podjarny, Jeff Bezos, Paul Graham, Richard Branson, Ron Suber, Sam Altman, Stanley Tang, Galaxy Digital, Lerer Hippeau, StepStone Group |
| Oct 1, 2021 | Bardavon Health Innovations | $90.0M Series C | Karan Takhar | WestCap |
| Sep 1, 2021 | Blockdaemon | $160.0M Series B | Softbank Group | Andreessen Horowitz, Bain Capital Ventures, B Capital Group, Boldstart Ventures, Bora&Sons, Founders Fund, Gaingels, GitHub Fund, Great Oaks Venture Capital, Hitachi Ventures, Laurence Jones, Sapphire Ventures, Streamlined Ventures, SV Angel, Tenaya Capital, Thomvest Ventures, Trajectory Ventures, Uncork Capital, UpHonest Capital, Walden Catalyst Ventures, Workday Ventures, Y Combinator, Adam Gross, Edith Harbaugh, Guy Podjarny, Jeff Bezos, Paul Graham, Richard Branson, Sam Altman, Borderless Capital, CoinFund, Oli Harris, Greenspring Associates, Kenetic Capital, Kraken Ventures, Lerer Hippeau, Morgan Creek Digital |
| Aug 1, 2021 | GentiBio | $160.0M Series A | Andy Tran | Matrix Capital Management Company, Avidity Partners, JDRF T1D Fund, Novartis, OrbiMed, RA Capital Management, Seattle Children's Research Institute |
| May 25, 2021 | Emboline | $55.0M Series D | Eric Xiao | Global Assets Investment, ShangBay Capital, SV Tech Ventures |
| Mar 22, 2021 | Aura Biosciences | $80.0M Other Equity | Karan Takhar, Surveyor Capital | Adage Capital Management, Advent Life Sciences, Arix Bioscience, Chiesi Ventures, Columbus Venture Partners, Lundbeckfond Ventures, Medicxi, Rock Springs Capital, Velosity Capital, Joel Jean Mairet |
| Mar 1, 2021 | ElevateBio | $530.0M Series C | — | Stuart Peterson, Cisco Investments, DFJ, Kevin Ding, Felicis Ventures, Foundation Capital, General Catalyst, Madrona Ventures, Next47, Sequoia Capital, Wing Venture Capital, Fidelity Management & Research Company, Karan Takhar, Deep Nishar |
| Jan 15, 2021 | AltPep | $23.1M Series A | Matrix Capital Management | Alexandria Venture Investments |
| Sep 17, 2020 | Palleon Pharmaceuticals | $100.0M Series B | Karan Takhar | AbbVie Ventures, SR One, Surveyor Capital, Takeda Ventures, Vertex Ventures HC |
| Jul 1, 2020 | VelosBio | $140.0M Series B | Karan Takhar, Surveyor Capital | Arix Bioscience, MPM Capital, Adage Capital Management, Cormorant Asset Management, Decheng Capital, Farallon Capital Management, Foresite Capital, Janus Henderson Investors, Logos Capital, OrbiMed, Pappas Capital, Sofinnova Ventures, Takeda Ventures, T. Rowe Price Associates, Venrock, Viking Global Investors, Wellington Management |
| Jul 1, 2020 | Encoded Therapeutics | $140.0M Series D | GV | Menlo Ventures, Anne Wojcicki, ARCH Venture Partners, Boxer Capital, Farallon Capital Management, HBM Genomics, Illumina Ventures, Menlo Ventures, Meritech Capital Partners, Nolan Capital, Perceptive Advisors, RTW Investments, SoftBank |
| Jun 1, 2019 | Encoded Therapeutics | $100.0M Series C | — | Menlo Ventures, Alexandria Venture Investments, Altitude Life Science Ventures, Robert Nelsen, Boxer Capital, Illumina Ventures, Karan Takhar, Menlo Ventures, RTW Investments, Bryan Roberts |
| Jun 6, 2018 | nference | $11.0M Series A | Matrix Partners | — |
| Jul 14, 2017 | Qrativ | $8.3M Series A | — | Matrix Partners, Clark Otley |
| Feb 4, 2016 | EpiBiome | $6.0M Series A | — | Alexandria Venture Investments, CRCM Ventures, Benard Joseph Yu, Viking Global Investors |
| May 7, 2015 | Adaptive Biotechnologies | $195.0M Series F | David Goel | — |
